|
||
|
Metabolism (A) and plasma level of carbamazepine in people with slow metabolic phenotype (B). |
|
||||||||
| Part of: Alvarado AT, Paredes G, García G, Morales A, Muñoz AM, Saravia M, Losno R, Bendezú MR, Chávez H, García JA, Pineda M, Sullón-Dextre L (2022) Serum monitoring of carbamazepine in patients with epilepsy and clinical implications. Pharmacia 69(2): 401-406. https://doi.org/10.3897/pharmacia.69.e82425 |